Fierce Health Payers November 11, 2021
As it builds more evidence to support its virtual reality therapeutic for managing pain, startup AppliedVR picked up $36 million in fresh funding to fuel its growth.
The Los Angeles-based company also is awaiting a decision from the Food and Drug Administration (FDA) on its first de novo submission. The company is preparing for full market launch of its flagship product, EaseVRx, after FDA approval.
With this funding, AppliedVR also has its sights set on additional payer pilots, building out its product pipeline, conducting more clinical research and continuing to build its VR pharmacy platform, executives said.
The series B funding included investments from F-Prime Capital, JAZZ Venture Partners, Sway Ventures and SVB Ventures. The company has raised $71 million...